6Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation [J]. 2002,105:2392～2397.
7Knudsen CW, Westheim A, Omland T, B-type natriuretic peptide and clinical judgement in the diagnosis of heart failure in patients presenting with acute dyspnoca [J]. Tidsskr Nor Laegeforen, 2003,123(5):2045～2048.
8Pesola GR, The use of B-type natriuretic peptide (BNP) to distinguish heart failure from lung disease in patients presenting with dyspnea to the emergency department[J]. Acad Emerg Med, 2003,10(3):275 ～ 7.
9Maron BJ, Tholakanahalli VN, et al. Usefulness of B-Type Natriuretic Peptide Assay in the Assessmemt of Symptomatic State in Hypertrophic Cardiomyopathy[J]. Circulation, 2004 Fed 16.
10Rademaker MT, Charles CJ,Espiner EA,Frampton CM,Nicholls MG,Richards AM.Combined inhibition of angiotensin Ⅱ and endothelin suppresses the brain natriuretic peptide response to developing heart failure[J] .Clin Sci (Lond).2004 Jan 14.
4Srichang N, Jiamjarasrangsi W, Aekplakom W,Supakankunti S. Cost and effectiveness of screeningmethods for abnormal fasting plasma glucose .nong Thaiadults participating in the annual health check-up atKing Chulalongkom Memorial Hospital[J].J Med Assoc.Thai, 2011, 94 ( 7) :833-841.
